Deliverable defines efficient business models for sustaining OurMED services and products post-project.
This Deliverable (D8.3.2) is an updated version of D8.3 delivered on Month 24. The objective of this deliverable is to define and structure effective business models and exploitation pathways that ensure the successful uptake of OurMED services and products beyond the project’s lifetime. Building on the identification of OurMED Key Exploitable Results (KERs).
No takes yet. Share an insight, caveat, or question.
Oueslati et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: